XBiotech Inc. - Common Shares, no par value (XBIT)

58 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q2 2024.
XBiotech Inc. - Common Shares, no par value (XBIT) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,516,257 shares of 33,289,095 outstanding shares and own 13.57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,134,146 shares), VANGUARD GROUP INC (1,036,969 shares), GEODE CAPITAL MANAGEMENT, LLC (430,205 shares), MILLENNIUM MANAGEMENT LLC (361,661 shares), UBS ASSET MANAGEMENT AMERICAS LLC (248,270 shares), STATE STREET CORP (202,843 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (154,178 shares), MORGAN STANLEY (100,551 shares), Bank of New York Mellon Corp (98,314 shares), and NORTHERN TRUST CORP (78,407 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.